{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:42:25Z","timestamp":1791492145601,"version":"4.3.4"},"reference-count":30,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,7,11]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Crohn\u2019s disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) with a relapsing-remitting nature. With adequate non-invasive prediction of mucosal inflammation, endoscopies can be prevented and treatment optimised earlier for better disease control. We aim to validate and recalibrate commonly used patient-reported symptom scores combined with a faecal calprotectin (FC) home test as non-invasive diagnostic tool for remote monitoring of IBD, both in daily practice and in a strict trial setting. Endoscopy will be used as the gold standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>In this multicentre prospective validation study, adult IBD patients are asked to fill out questionnaires regarding disease activity (Monitor IBD At Home, mobile Health Index, Manitoba IBD Index, IBD control and patient-HBI\/patient-Simple Clinical Colitis Activity Index), perform a FC home test and collect a stool sample for routine laboratory FC measurement, before the start of the bowel preparation for the ileocolonoscopy. Endoscopic disease activity will be scored according to the simplified endoscopic score for Crohn\u2019s disease (CD) for CD patients or Ulcerative Colitis Endoscopic Index for Severity and Mayo Endoscopic Subscore for ulcerative colitis patients. The main study outcome is the diagnostic test accuracy of the various patient-reported scores to assess mucosal inflammation in combination with a FC home test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study is approved by the Medical Research Ethics Committee of azM\/UM in Maastricht dated 03 March 2021 (METC 20\u2013085) and is monitored by the Clinical Trial Centre Maastricht according to Good Clinical Practice guidelines. Written informed consent will be obtained from all patients. Study results will be published in international peer-reviewed medical journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05886322\">NCT05886322<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-076290","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T23:05:45Z","timestamp":1728342345000},"page":"e076290","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting mucosal inflammation in IBD patients using patient-reported symptom scores and a faecal calprotectin home test: protocol for a multicentre prospective validation study"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct05886322","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-8665","authenticated-orcid":false,"given":"Laura","family":"Janssen","sequence":"first","affiliation":[{"name":"NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, Limburg, Netherlands"},{"name":"Gastroenterology and Hepatology, Maastricht UMC+, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-596X","authenticated-orcid":false,"given":"Reinier Cornelis Anthonius","family":"van Linschoten","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Franciscus Gasthuis en Vlietland, Rotterdam, Netherlands"},{"name":"Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Louise","family":"West","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Franciscus Gasthuis, Rotterdam, Zuid-Holland, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennard P L","family":"Gilissen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Catharina Hospital, Eindhoven, North Brabant, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00eblle","family":"Romberg-Camps","sequence":"additional","affiliation":[{"name":"Gastroenterology, Zuyderland Medical Centre Sittard-Geleen, Sittard-Geleen, Limburg, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0620-1271","authenticated-orcid":false,"given":"Lloyd","family":"Brandts","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht UMC+, Maastricht, Limburg, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatan","family":"Mujagic","sequence":"additional","affiliation":[{"name":"NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, Limburg, Netherlands"},{"name":"Division of Gastroenterology-Hepatology, Maastricht University Medical Centre+, Maastricht, Limburg, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa EH","family":"R\u00f6mkens","sequence":"additional","affiliation":[{"name":"Department of Gastroenteroloy and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, Noord-Brabant, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pierik","sequence":"additional","affiliation":[{"name":"NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, Limburg, Netherlands"},{"name":"Department of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, Limburg, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"2025121605093262000_14.10.e076290.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.150"},{"key":"2025121605093262000_14.10.e076290.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00360-x"},{"key":"2025121605093262000_14.10.e076290.3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ecco-jcc\/jjx055","article-title":"A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort-Can Diagnostic Factors Explain the Increase in IBD Incidence?","volume":"11","author":"van den Heuvel","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2025121605093262000_14.10.e076290.4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.16445","article-title":"Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents","volume":"54","author":"van Linschoten","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121605093262000_14.10.e076290.5","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx100"},{"key":"2025121605093262000_14.10.e076290.6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)31711-1"},{"key":"2025121605093262000_14.10.e076290.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2"},{"key":"2025121605093262000_14.10.e076290.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"2025121605093262000_14.10.e076290.9","doi-asserted-by":"publisher","DOI":"10.1093\/ECCO-JCC\/JJY113"},{"key":"2025121605093262000_14.10.e076290.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)01878-4"},{"key":"2025121605093262000_14.10.e076290.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300486"},{"key":"2025121605093262000_14.10.e076290.12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ecco-jcc\/jjad018","article-title":"Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial","volume":"17","author":"Schreiber","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2025121605093262000_14.10.e076290.13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(17)31327-2","article-title":"Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial","volume":"390","author":"de Jong","year":"2017","journal-title":"Lancet"},{"key":"2025121605093262000_14.10.e076290.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.12.014"},{"key":"2025121605093262000_14.10.e076290.15","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000341"},{"key":"2025121605093262000_14.10.e076290.16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/ecco-jcc\/jjy196","article-title":"Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease","volume":"13","author":"de Jong","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2025121605093262000_14.10.e076290.17","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.cgh.2015.10.035","article-title":"Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies","volume":"14","author":"Van Deen","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121605093262000_14.10.e076290.18","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31828b2196"},{"key":"2025121605093262000_14.10.e076290.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.11.007"},{"key":"2025121605093262000_14.10.e076290.20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/ecco-jcc\/jjaa057","article-title":"Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?","volume":"14","author":"van Andel","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2025121605093262000_14.10.e076290.21","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab082"},{"key":"2025121605093262000_14.10.e076290.22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305600"},{"key":"2025121605093262000_14.10.e076290.23","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.197"},{"key":"2025121605093262000_14.10.e076290.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32641-7"},{"key":"2025121605093262000_14.10.e076290.25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/ecco-jcc\/jjab055","article-title":"Validation of the \u201cInflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score\u201d for Ulcerative Colitis and Crohns Disease","volume":"15","author":"Lang-Schwarz","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2025121605093262000_14.10.e076290.26","doi-asserted-by":"crossref","unstructured":"Vespa E , D\u2019Amico F , Sollai M , et al . Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art. J Clin Med 2022;11. doi:10.3390\/jcm11040939","DOI":"10.3390\/jcm11040939"},{"key":"2025121605093262000_14.10.e076290.27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.404"},{"key":"2025121605093262000_14.10.e076290.28","doi-asserted-by":"crossref","unstructured":"Vickers AJ , van Calster B , Steyerberg EW . A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res 2019;3. doi:10.1186\/s41512-019-0064-7","DOI":"10.1186\/s41512-019-0064-7"},{"key":"2025121605093262000_14.10.e076290.29","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30300-9"},{"key":"2025121605093262000_14.10.e076290.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214751","article-title":"Head-to-head comparison of three stool calprotectin tests for home use","volume":"14","author":"Haisma","year":"2019","journal-title":"PLoS One"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-076290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:09:39Z","timestamp":1765890579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-076290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,7]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/bmjopen-2023-076290"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-076290","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}